Skip to main content
    A

    Alto Neuroscience, Inc. (ANRO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NYSE

    $24.92
    -2.20 (-8.11%)

    Market Cap: $1.09B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Alto Neuroscience, Inc. (ANRO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Alto Neuroscience (ANRO) has a latest price of $24.92 on Nov 17, 2026, 33.5% below its 52-week high of $37.48. Its price rose 105.8% over the past 12 months.

    Price Chart

    From Feb 2024 to Oct 2026, its highest month-end close was $35.38 in Aug 2026 and its lowest $2.16 in Mar 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ANRO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ANRO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 28.6%, and over 6 months it rose 21.9%.

    PeriodChange
    1 month+9.2%
    3 months-28.6%
    6 months+21.9%
    12 months+105.8%
    12 months, with dividends+105.8%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$22.60+27.0%
    2025$17.80+320.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 4.1% below its 50-day average of $25.98 and 0.3% above its 200-day average of $24.84.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$24.92
    52-week high$37.48-33.5%
    52-week low$12.51+99.2%
    50-day average$25.98-4.1%
    200-day average$24.84+0.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 91.7%.

    MeasureValue
    1-year beta1.78
    Largest fall, 1 year-40.7%
    Largest fall, 3 years-91.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ANRO

    What is ANRO's 1-year price change?

    Alto Neuroscience's price rose 105.8% over the past 12 months. With dividends included, the 12-month total return was 105.8%.

    What is ANRO's 52-week high and low?

    Alto Neuroscience's 52-week high is $37.48 and its 52-week low is $12.51. Its latest price of $24.92 on Nov 17, 2026 is 33.5% below the high.

    What is ANRO's beta?

    Alto Neuroscience's 1-year beta against the S&P 500 is 1.78, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 40.7%.

    Is the ANRO chart free?

    Yes. Advanced Charting for ANRO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.